Shares in Xeris Pharmaceuticals are rising 9% in Wednesday’s pre-market session after the company announced that the US Food and Drug Administration (FDA) granted Fast Track designation for its XP-0863
Shares in Xeris Pharmaceuticals are rising 9% in Wednesday’s pre-market session after the company announced that the US Food and Drug Administration (FDA) granted Fast Track designation for its XP-0863
Breaking record after record, the stock market is on a roll. Hovering at all-time highs, the steady decline of new COVID-19 cases in the U.S. and vaccine hopes have kept
Xeris Pharmaceuticals (XERS) spiked 12% in Friday’s after-hours trading after a filing disclosed that Soros Fund Management, LLC holds a 5.3% stake in the company with ~2.5M common shares. Soros
With the outbreak of the coronavirus, volatility has become a seemingly ever-present facet of the stock market. While the current economic landscape has spurred fear among investors, others view market
